Description
Release form
Film-coated tablets.
Packing
28 pcs.
Pharmacological action
Montelar – blocker of cysteinyl leukotriene receptors CysLT1 (leukotrienes C4, D4 and E4 – mediators of chronic persistent inflammation, supporting bronchial hyperresponsiveness in bronchial asthma).
Prevents excessive secretion in the bronchi, swelling of the mucous membrane of the respiratory tract. Reduces the severity of bronchial asthma and the frequency of asthmatic attacks. Highly effective when taken orally.
Bronchodilator action develops within 1 day and lasts a long time.
Effective in patients with mild persistent asthma, not sufficiently controlled by bronchodilators alone.
Contraindications
Hypersensitivity, children’s age (up to 6 years).
Caution. Pregnancy, lactation.
Special instructions
It is recommended that you continue to take it after you have achieved a significant improvement.
Should not be used to relieve acute asthmatic attacks, does not replace inhaled bronchodilators.
Composition
1 tablet contains 10 mg montelukast.
Dosage and Administration
Inside, regardless of food intake.
Adults and teenagers over 15 years of age – 10 mg once a day, at bedtime.
Side effects
abdominal pain, headache, nausea, flu-like syndrome, cough, sinusitis, pharyngitis, increased activity of hepatic transaminases, allergic reactions.
Storage conditions
In a place protected from light and moisture, at a temperature not exceeding 30 ° C.
Keep out of the reach of children.
Expiration
2 years.
Active ingredient
Montelukast
Conditions for the drugstore from
By recipe
Dosage form
tablets
Appointment
Children by doctor’s appointment, Adults by doctor’s appointment, Children over 15 by
Indications
Bronchitis, From respiratory tract infections, From boils, From otitis, From pyoderma, From sore throat, From cystitis, From urethritis, From urinary tract infections, From skin infections, From pharyngitis8 onhospazm, Bronhyalnaya asthma
Sandoz, Switzerland
